Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci

• DOI: 10.1111/j.1469-0691.2007.01840.x
• Publication Date: 2007-11-16T01:26:16Z
• Authors: V. Sakka; S. Tsiodras; L. Galani; A. Antoniadou; M. Souli; I. Galani; M. Pantelaki; N. Siafakas; L. Zerva; H. Giamarellou
• Keywords: Microbiology (medical); Male; Time Factors; Feces; 03 medical and health sciences; enterococci; Risk Factors; Prevalence; Humans; risk-factors; Gram-Positive Bacterial Infections; Aged; Cross Infection; 0303 health sciences; Colonisation; Vancomycin Resistance; Middle Aged; vancomycin-resistant enterococci; mortality; Anti-Bacterial Agents; 3. Good health; Infectious Diseases; vancomycin resistance; Case-Control Studies; Multivariate Analysis; Female; Enterococcus

Vancomycin-resistant enterococci (VRE) have emerged as significant nosocomial pathogens. A hospital-wide prevalence study was performed to identify cases with VRE faecal colonisation. A case-control study using two randomly selected VRE-negative controls for each positive case was performed to assess risk-factors for VRE colonisation by univariate and multivariate analysis. VRE faecal colonisation was documented in 53 (14.3%) of 370 patients screened. Previous exposure to anti-anaerobic agents, as well as quinolones, was associated with VRE colonisation (p <0.05). The presence of an invasive device (OR 4.8, p 0.003) and the duration of any antimicrobial treatment before VRE isolation (OR 1.2, p <0.001) predicted VRE colonisation in multivariate models. The crude mortality rate for patients with VRE colonisation was 24.5%, but VRE colonisation was not an independent predictor of mortality in these patients. These results suggest that an active surveillance programme focusing on specific patient groups may help in the identification of VRE-colonised patients. Promptly implemented infection control strategies targeting these groups should help to combat the rising incidence of VRE.